1-2 of 2
Keywords: Goserelin acetate
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

3-Month Formulation of Goserelin Acetate (‘Zoladex’ 10.8-mg Depot) in Advanced Prostate Cancer: Results from an Italian, Open, Multicenter Trial

Available to Purchase
Subject Area:
Further Areas
D. Fontana, M. Mari, A. Martinelli, C. Boccafoschi, C. Magno, M. Turriziani, S.S. Maymone, S. Cosciani Cunico, A. Zanollo, G. Montagna, M. Frongia, U. Jacobellis
Journal: Urologia Internationalis
Urol Int (2003) 70 (4): 316–320.
https://doi.org/10.1159/000070142
Published Online: 14 May 2003
...D. Fontana; M. Mari; A. Martinelli; C. Boccafoschi; C. Magno; M. Turriziani; S.S. Maymone; S. Cosciani Cunico; A. Zanollo; G. Montagna; M. Frongia; U. Jacobellis Objectives: To determine the endocrine effects, efficacy and tolerability of the 3-month formulation of goserelin acetate (‘Zoladex’ 10.8...
View article titled, 3-Month Formulation of Goserelin Acetate (‘Zoladex’ 10.8-mg Depot) in Advanced Prostate Cancer: Results from an Italian, Open, Multicenter Trial
Open the PDF for 3-Month Formulation of Goserelin Acetate (‘Zoladex’ 10.8-mg Depot) in Advanced Prostate Cancer: Results from an Italian, Open, Multicenter Trial in another window
Journal Articles

Prostate-Specific Antigen Dynamics Predict Risk of Progression in Advanced Prostate Cancer Treated with Bicalutamide plus Castration

Available to Purchase
Subject Area:
Further Areas
Jens E. Altwein, Andreas Schmidt
Journal: Urologia Internationalis
Urol Int (2002) 68 (4): 220–225.
https://doi.org/10.1159/000058439
Published Online: 31 May 2002
... bicalutamide (50 mg once daily) plus either goserelin acetate or surgical castration for 48 weeks. Cox’s proportional hazard analysis was used to determine whether the decline of PSA following the use of this combination is predictive of a delay in progression. Results: PSA levels at weeks 4 and 12 were...
View article titled, Prostate-Specific Antigen Dynamics Predict Risk of Progression in Advanced Prostate Cancer Treated with Bicalutamide plus Castration
Open the PDF for Prostate-Specific Antigen Dynamics Predict Risk of Progression in Advanced Prostate Cancer Treated with Bicalutamide plus Castration in another window